SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

6 Months Ended

Jun. 30, 2012

Financial Instruments Where Carrying Value and Fair Value Differ

The following details our financial instruments where the carrying value and the fair value differ (amounts in millions):

	Fair Value at Reporting Date Using
Financial Instrument	As of June 30, 2012		Quoted Prices in Active Markets for Identical Items (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Long-term obligations, excluding capital leases	$	128.4	$	—	$	134.6	$	—

Weighted-Average Shares Outstanding

The following table sets forth, for the periods indicated, shares used in our computation of the weighted-average shares outstanding, which are used to calculate our basic and diluted net income attributable to Amedisys, Inc. common stockholders (amounts in thousands):

	For the  Three-Month Periods Ended June 30,				For the  Six-Month Periods Ended June 30,
	2012		2011		2012		2011
Weighted average number of shares outstanding - basic		29,780		28,625		29,584		28,495
Effect of dilutive securities:
Stock options		23		80		16		86
Non-vested stock and stock units		223		305		303		357
Weighted average number of shares outstanding - diluted		30,026		29,010		29,903		28,938
Anti-dilutive securities		531		2		595		—